ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Lactococcus lactis GV103, potentially probiotic, applied in the development of lactose-free fermented milk.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This study aimed to evaluate the effect of lactose and glucose on the viability of lactic acid bacteria (LAB) and assess the microbiological and technological characteristics of lactose-free milk fermented with the potentially probiotic strain Lactococcus lactis GV103. The viability of GV103, either alone or co-cultured with Streptococcus thermophilus STI-12, was evaluated in glucose (Glu), lactose (Lac), and glucose:lactose (Glu:Lac) media. After fermentation, pH, titratable acidity, syneresis, water-holding capacity (WHC), and LAB counts were monitored throughout 28 days of re-frigerated storage. Simulated gastrointestinal tract (GIT) conditions were also assessed for both LAB. When co-cultured, the Lac and Glu:Lac media reached pH 4.6 in approximately 480 min, while Glu required 703.5 min. As a monoculture, GV103 showed the highest counts in Glu:Lac, exceeding 10.50 log CFU/mL. After 28 days, the lactose-free fermented milk had a pH of 3.84 and a titratable acidity of 1.10 g lactic acid/100 mL. Syneresis and WHC were 42.32% and 34.62%, respectively. LAB viability remained above 10.50 log CFU/mL after storage, and both strains survived simulated GIT conditions with counts exceeding 9.00 log CFU/mL. The GV103 and STI-12 proved to be effective, supporting its potential for future probiotic applications in lactose-free dairy products, with attention to fermentation time. The results of this study are promising regarding the use of this microorganism to produce lactose-free fermented milk. However, further studies involving sensory analysis are recommended to assess consumer acceptance, as well as large-scale production to evaluate industrial feasibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.